Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007
Date:2/4/2008

/p>

evaluation of the Company's current operating performance and

comparison to the Company's past operating performance.

Material Limitations Associated with the Use of Non-GAAP Financial

Measures

Non-GAAP net income, non-GAAP net income per diluted share, and regional

and divisional revenue growth rates that exclude the impact of foreign

exchange may have limitations as analytical tools, and these non-GAAP

measures should not be considered in isolation or as a replacement for

GAAP financial measures. Some of the limitations associated with the use

of these non-GAAP financial measures are:

-- Items such as purchased research and development, the step-up value of

acquired Guidant inventory sold during the period, the CRM technology

offering charge, the loss on assets held for sale, and the fair value

adjustment related to the sharing of proceeds feature of the Abbott

stock purchase reflect economic costs to the Company and are not

reflected in non-GAAP net income and non-GAAP net income per diluted

share.

-- Items such as Guidant integration costs, facility and severance costs,

employee-related costs associated with certain business optimization

initiatives, the charitable contribution, and restructuring and

litigation-related expenses that are excluded from non-GAAP net income

and non-GAAP net income per diluted share can have a material impact on

cash flows and GAAP net income and net income per diluted share.

-- Items such as amortization of purchased intangible assets, though not

directly affecting Boston Scientific's cash flow position, represent a

reduction in value of intangible assets over time. The expense

associated with this reduction in value is not included in Boston

Scientific's non-GAAP net income or non-GAAP net income per diluted


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. Boston Scientific to Participate in Merrill Lynch Conference
2. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
3. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
4. Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
5. Boston Scientific Announces Results for Third Quarter Ended September 30, 2007
6. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
7. The 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Nov. 2-6
8. Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator
9. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
10. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
11. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015  AmnioChor Inc., an early stage biotech startup ... to announce that the Musculoskeletal Transplant Foundation of ... in their seed round of development of the proprietary ... AmnioChor,s technology allows cryopreservation of the ... cells living within those tissues. Amnion is a well-established ...
(Date:7/29/2015)... July 29, 2015  Indivior PLC (LON: INDV) today ... nasal spray was accepted and received Priority Review by ... treatment of opioid overdose. This naloxone nasal spray comes ... for optimal absorption into the nasal mucosa. 1 ... so individuals may be better equipped to help an ...
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... has selected an optimized Erk inhibitor molecule for ... development of a new class of potential cancer ... a prime target for therapeutic intervention in cancer. ... survival benefits for B-Raf and Mek inhibitors. Erk ...
(Date:7/29/2015)... ... 29, 2015 , ... Available in select spas and ... nighttime-specific product that targets fat cells for extreme contouring action. During sleep key ... cells, inhibiting the formation of new fat. Upon waking CHRONODIET breaks down fat ...
Breaking Biology Technology:The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3
... May 22 SuperGen, Inc.,(Nasdaq: SUPG ... discovery, rapid,development and commercialization of therapies for ... Michael Molkentin, C.P.A.,Chief Financial Officer and Corporate ... President of Drug Discovery Operations, are scheduled,to ...
... PHILLIPSBURG, N.J., May 22 Celldex,Therapeutics (a wholly-owned ... that its lead product,candidate, CDX-110, being developed for ... subject of an oral presentation at the 44th,Annual ... (ASCO). The,ASCO meeting will be held at McCormick ...
... AMSTERDAM, The Netherlands, May 22 Amsterdam,Molecular ... field of human gene,therapy, today announced that ... in Rome, Italy, to their advanced small ... of Duchenne,muscular dystrophy (DMD). The combination with ...
Cached Biology Technology:SuperGen to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 29, 2008 2AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual Meeting 2AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual Meeting 3AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy 2AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy 3
(Date:7/7/2015)... 2015 Research and ... of the "Capacitive Fingerprint Sensors Patent Landscape" ... this date, fingerprint sensing technology is the most ... are well developed. This patent landscape focuses on ... The domain of capacitive fingerprint sensors is closely ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ) ... Biometrics Market by Application, Technology, Function & Geography - ... The next generation biometrics market is expected ... of 17.9% between 2015 and 2020 Travel ... Safran SA ( France ), ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Latin America Biomedical Sensors Market Report 2015-2020 2
... (Feb. 6, 2014) Declines in the underlying brain skills ... In fact, this cognitive decline is a fact of life ... the cognitive health of older adults are critically important for ... activity and cognitive training are among the efforts aimed at ...
... at Rice University and the University of Texas Medical ... sensitive and efficient test for the diarrheal disease cryptosporidiosis ... Results from the diagnostic developed by the lab of ... strip that resembles a pregnancy test. Lines on the ...
... have for the first time sequenced an ancient RNA genome ... old - pushing its origin back at least 2,000 years and ... to its spread., Researchers at the University of Warwick have detected ... in a 750-year-old barley grain found at a site near the ...
Cached Biology News:Nutritional supplement improves cognitive performance in older adults, study finds 2Nutritional supplement improves cognitive performance in older adults, study finds 3Quick test finds signs of diarrheal disease 2Quick test finds signs of diarrheal disease 3RNA sequencing of 750-year-old barley virus sheds new light on the Crusades 2RNA sequencing of 750-year-old barley virus sheds new light on the Crusades 3
Special grade: for molecular biology Density: 1.000 g/mL (20 C)...
Mol wt: average mol wt12,360.96 Da by calculation...
... Grace's medium were developed in several laboratories ... of these modifications were developed by Dr. ... derived from the cabbage looper,Tricoplusia ni. This ... The medium when properly supplemented has been ...
... clear polystyrene with frosted labeling surfaces, ... cell counting. 100% integrity tested. Linkage: ... product number, created to easily match ... availability yet, please order under the ...
Biology Products: